News & Updates
Filter by Specialty:

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025
byAudrey Abella
In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025
Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab
28 Mar 2025
byStephen Padilla
The use of lebrikizumab improves the symptoms of moderate-to-severe atopic dermatitis (AD) in patients previously treated with dupilumab, reports a study presented at AAD 2025.